Paper35486115
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M and 1 other. Immunol Res, 2022. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors. Papers, record 35486115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35486115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Humans | |
| Immunotherapy | |
| Macrophages | |
| Transcription Factors |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22025054 | Transcriptional regulation of macrophage polarization: enabling diversity with identity. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/22025054 | PubMed |
| 2 | 32953830 | Metabolic reprograming of tumor-associated macrophages. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/32953830 | PubMed |
| 3 | 29313005 | Biomimetic strategies for targeted nanoparticle delivery. | Bioeng Transl Med | 2016 | https://conductscience.org/library/papers/29313005 | PubMed |
| 4 | 32724855 | M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects. | ACS Cent Sci | 2020 | https://conductscience.org/library/papers/32724855 | PubMed |
| 5 | 31419588 | Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines. | Biomaterials | 2019 | https://conductscience.org/library/papers/31419588 | PubMed |
| 6 | 32849616 | Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849616 | PubMed |
| 7 | 16239969 | Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16239969 | PubMed |
| 8 | 25339958 | Macrophage cytokines: involvement in immunity and infectious diseases. | Front Immunol | 2014 | https://conductscience.org/library/papers/25339958 | PubMed |
| 9 | 20103670 | Nuclear factor-kappaB and tumor-associated macrophages. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20103670 | PubMed |
| 10 | 30413827 | Cytokines in clinical cancer immunotherapy. | Br J Cancer | 2019 | https://conductscience.org/library/papers/30413827 | PubMed |
| 11 | 32599709 | Macrophage Modification Strategies for Efficient Cell Therapy. | Cells | 2020 | https://conductscience.org/library/papers/32599709 | PubMed |
| 12 | 25314115 | Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. | Mol Pharm | 2014 | https://conductscience.org/library/papers/25314115 | PubMed |
| 13 | 18617992 | RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. | PLoS Pathog | 2008 | https://conductscience.org/library/papers/18617992 | PubMed |
| 14 | 32547552 | Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles. | Front Immunol | 2020 | https://conductscience.org/library/papers/32547552 | PubMed |
| 15 | 26614117 | Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis. | Microcirculation | 2016 | https://conductscience.org/library/papers/26614117 | PubMed |
| 16 | 26335330 | Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. | PLoS One | 2015 | https://conductscience.org/library/papers/26335330 | PubMed |
| 17 | 29155869 | NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment. | PLoS One | 2017 | https://conductscience.org/library/papers/29155869 | PubMed |
| 18 | 24379524 | Interferon-regulatory factors determine macrophage phenotype polarization. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/24379524 | PubMed |
| 19 | 25125485 | Tumor-associated macrophages as major players in the tumor microenvironment. | Cancers (Basel) | 2014 | https://conductscience.org/library/papers/25125485 | PubMed |
| 20 | 23640482 | Transcriptional control of macrophage polarization. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23640482 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42111497 | Multiomics Characterization of GCSH + Macrophages Reveals Therapeutic Vulnerabilities and Immune-Metabolic Crosstalk in Triple-Negative Breast Cancer. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42111497 | PubMed |
| 41147952 | Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/41147952 | PubMed |
| 40075571 | Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075571 | PubMed |
| 38165530 | The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strains. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38165530 | PubMed |
| 37894541 | Dendrobium officinale polysaccharide Converts M2 into M1 Subtype Macrophage Polarization via the STAT6/PPAR-r and JAGGED1/NOTCH1 Signaling Pathways to Inhibit Gastric Cancer. | Molecules | 2023 | https://conductscience.org/library/papers/37894541 | PubMed |
| 36418765 | Immunotherapeutic effects of intratumorally injected Zymosan-Adenovirus conjugates encoding constant active IRF3 in a melanoma mouse model. | Immunol Res | 2023 | https://conductscience.org/library/papers/36418765 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35486115
GET https://conductscience.org/api/papers/v1/35486115/references?page=2